1 / 6

Cell Therapy Market Growth, Global Survey, Analysis 2027

The global Cell Therapy Market is forecasted to grow at a rate of 5.6% from USD 5.79 Billion in 2019 to USD 8.75 Billion in 2027. The factors affecting the market are the growing public recognition about the therapeutic strength of products, rising public-private investments, and development of regulatory framework for stem cell therapeutics. They are affecting the growth of the market positively.

industrytrends
Télécharger la présentation

Cell Therapy Market Growth, Global Survey, Analysis 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cell Therapy Market To Reach USD 8.75 Billion By 2027

  2. Market Summary The increasing cases of osteoporosis globally, growing lifestyle diseases and the rising geriatric population are some major factors which are expected to drive the market in the forecast period. The global Cell Therapy Market is forecast to reach USD 8.75 Billion by 2027, according to a new report by Reports and Data. The market for cell therapy is observing a high demand due to the rise in the number of clinical trials across the world. These therapies are used in regenerative medicine, especially for degenerative and immunogenic pathologies. However, the applications of cell therapy in oncology will experience higher growth, owing to a large number of pipeline projects for the treatment of tumors or cancer. Further key findings from the report suggest Allogeneic Stem Cell Therapy dominated the therapy type segment. The segment is advantageous as they produce their own immune stem cells, which can kill cancer cells that remain even after high-dose cytotoxic drugs treatment. The patients those have a high risk of relapse after successful treatment of chemotherapy are recommended allogeneic transplants. The rising cases of cancer relapse have fueled the demand for the segment. Stem cell banking is gaining popularity from the initiatives taken by the government. The number of stem cell banks are increasing in developing nations, which is further propelling market growth. Also, increasing awareness regarding the storage of stem cells has had a positive effect on the market. The market is still at a nascent stage, but it holds potential in both therapeutic and diagnosis fields. Hospitals and clinics are forecasted to grow at a significant CAGR of 5.8% during the forecast period. The lucrative growth in the segment is due to the increase in the number of pipeline projects over the past few years. As per the Cancer Research Institute (CRI), the number of projects rose from 753 in 2018 to 1,011 in 2019.

  3. Market Summary KeyPlayers: JCR Pharmaceuticals Co. Ltd., Fibrocell Science, Inc., KolonTissueGene, Inc., Osiris Therapeutics, Inc., PHARMICELL Co., Ltd., MEDIPOST, Stemedica Cell Technologies, Inc., Cells for Cells, Vericel Corporation, and ANTEROGEN Co., Ltd., among others. Segmentation: Therapy Type Outlook (Revenue, USD Billion; 2017-2027) Allogenic Stem Cell Therapy Autologous Stem Cell Therapy Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027) Malignancies Autoimmune Disorders Musculoskeletal Disorders Dermatology Others Cell Type Outlook (Revenue, USD Billion; 2017-2027) Stem Cells Non-Stem Cells Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3269

  4. Market Summary • End-User Outlook (Revenue, USD Billion; 2017-2027) • Hospitals & Clinics • Academic & Research Institutes • Regional Outlook (Revenue, USD Billion; 2017-2027) • North America • U.S • Canada • Europe • Germany • U.K • France • BENELUX • Rest of Europe • Asia Pacific • China • Japan • Latin America • MEA • Rest of MEA Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3269

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period?

  6. About US Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related